AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04969393 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Physical Therapy
Description: Fifteen treatment sessions that involved using a neutral custom volar splint alongside neural and tendon gliding exercises. the splint was used at night and while performing strenuous activities during the day for 5 weeks. While nerve and tendon gliding exercises was repeated 10 times at each session and patients were encouraged to apply exercise 3-5 times per day for 5 weeks.
Study NCT05894018 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fluzoparib
Description: 150mg, orally, bid
Study NCT05702762 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Gentamicin
Description: 5 mg/kg intramuscular injection
Study NCT05702762 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care
Description: Usual oral antibiotic multi-day dosing based on local antibiogram
Study NCT06065839 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: non-nutritive sucking 5 minutes
Description: Give pacifier non-nutritive sucking for 5 minutes before feeding
Study NCT06065839 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: non-nutritive sucking 15 minutes
Description: Give pacifier non-nutritive sucking for 15 minutes before feeding
Study NCT06782399 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Microdevice
Description: Device: Microdevices~The microdevice is an investigational miniaturized implantable nanodose drug delivery device. It was developed as a tool with the ultimate goal to help screen several existing and investigational drugs directly within a patient's tumor to identify what drugs are the most effective for treating a patient's cancer. The microdevice releases nanodoses of several approved drugs into the tumor, and is then excised minimally invasively several days later.~Other: Standard of care therapy~Participant to receive standard of care therapy as previously determined by participant's treating oncologist and/or dermatologist, which may include a skin-directed or systemic therapy
Study NCT06040606 — intervention group
Intervention type: PROCEDURE
Intervention: In-Hospital COVID-19 Omicron Infection after surgery
Description: Thoracic Surgery Patients with In-Hospital COVID-19 Omicron Infection after surgery
Study NCT05894018 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Radioactive particle implantation
Description: Radioactive iodine-125 seeds implantation
Study NCT04790006 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TG103
Description: Administered SC
Study NCT06780371 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Emotional Freedom Technique
Description: Emotional Freedom Technique application; It is an application that works on cognitive and energetic levels.~Emotional Freedom Technique Application Instructions~1. Determination of Subjective Units of Disturbance (SUD)~2. Preparation or setup~3. Application of appropriate acupuncture points in order~4. 9-Gamut: An application that allows the two hemispheres of the brain to be stimulated simultaneously~5. Application of appropriate acupuncture points in order again~6. Control of the differentiation in the level of discomfort with SUDS again
Study NCT04790006 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Administered SC
Study NCT06780228 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: chatbot-assisted clinical learning
Description: The participants will recevie a self-developed web-based chatbot platform which is accessible via smartphones. It provides real-time dialogue with the chatbot through texts, visual aids, and audio files. The intervention will be available throughout the 12-week study. the chatbot is characterized by a gender-neutral persona, assumes the role of a friendly and empathetic clinical mentor. Its communication style can be described as calm, tolerant, supportive, and appreciative. Participants will receive weekly SMS notifications to remind them to consult with the chatbot.
Study NCT06780631 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Web-based diabetic foot education based on health promotion model
Description: The first group can access the training at any time and repeat the training thanks to web-based training.
Study NCT06780631 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Face to face diabetic foot education based on health promotion model
Description: Individuals with Type 2 diabetes in the face-to-face training group will receive face-to-face diabetic foot training in line with the training booklet for approximately 45 minutes, one by one.
Study NCT06780150 — intervention group
Intervention type: DRUG
Intervention: Ocrelizumab
Description: Ocrelizumab will be administered as SC injection as per discretion of the treating physician in accordance with local clinical practice and local labeling.
Study NCT06780852 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Tetranite for Cranial Flap Fixation (TN-CFF)
Description: Bioresorbable bone adhesive for cranial flap fixation following a craniotomy.
Study NCT06780800 — intervention group
Intervention type: OTHER
Intervention: The Back Belief Questionnaire Tr (BBQ) and Backs-tr
Description: 200 people will be administered The Back Belief Questionnaire Tr (BBQ) and Backs-tr.
Study NCT06780800 — intervention group
Intervention type: OTHER
Intervention: Backs-tr retest
Description: 100 people will fill in the Backs-tr again after 1 week.
Study NCT06781645 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: The system involves a digital table with a tactile and interactive surface, providing several play areas. It simulates a village and offers different types of serious cognitive games: semantic memory
Description: Each patient included will benefit from a series of 6 sessions of cognitive stimulation with the interactive digital table of cognitive games 'Le Village de Verdurable'©, and a series of 6 sessions of 'classic' weekly cognitive stimulation at the rate of one session per week, i.e. without the digital table and using the methods of cognitive stimulation normally used in the department. The weekly session used as a comparator in the usual condition will be a session based on concentration and attention with target finding or error finding. The order in which these 2 series of 6 sessions will be carried out will be defined randomly (by drawing lots) before the start of the trial.
Study NCT06145490 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: OTHER
Intervention: Caffeine
Description: Caffeine capsule 250 mg, oral intake
Study NCT06145490 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Placebo
Description: Placebo capsule, oral intake
Study NCT05143190 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PTR-01
Description: Intravenous recombinant collagen 7
Study NCT06339658 — intervention group
Intervention type: PROCEDURE
Intervention: Targeted axillary dissection (TAD) by ICG
Description: Use of ICG during the targeted axillary dissection (TAD)
Study NCT06339658 — intervention group
Intervention type: PROCEDURE
Intervention: Targeted axillary dissection (TAD) by Blue patent
Description: Use of Blue patent during the targeted axillary dissection (TAD)
Study NCT05385835 — intervention group
Intervention type: OTHER
Intervention: Training
Description: A training module was prepared by explaining the theoretical and practical parts of the application of blood pressure measurement from the brachial artery with a slide presentation and an animation video. The knowledge and skills of nurses in blood pressure measurement before education were measured. The training module was delivered to the nurses from the online system. At the end of the two-week training period, the knowledge and skill levels of the nurses will be measured again.
Study NCT06500936 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: SMS
Description: The intervention included two series of SMS messages. First, women of IG received one weekly SMS messages for 2 weeks. Those women that did not register a mammography in SITAM 45 days after the 2nd message, received the second series, consisting of one weekly SMS message over two weeks.
Study NCT04084678 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ralinepag
Description: Oral ralinepag
Study NCT04084678 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching oral tablets
Study NCT04890743 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Kinesiotherapy combined with electrotherapy (Convenctional TENS method).
Description: One of the four groups created during randomization will undergo a unified program of kinesiotherapy and electrotherapy (Conventional TENS method).
Study NCT04890743 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Kinesiotherapy combined with electrotherapy (Pseudo-acupuncture TENS method).
Description: One of the four groups created during randomization will undergo a unified program of kinesiotherapy and electrotherapy (Pseudo-acupuncture TENS method).
Study NCT04890743 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Kinesiotherapy combined with electrotherapy (Trabert ultrastimulation method)
Description: One of the four groups created during randomization will undergo a unified program of kinesiotherapy and electrotherapy (Trabert ultrastimulation method).
Study NCT04890743 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Kinesiotherapy combined with placebo electrotherapy
Description: One of the four groups created during randomization will undergo a unified program of kinesiotherapy and placebo electrotherapy.
Study NCT05024318 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Pembrolizumab 200 mg tobe administered as a 30 minute IV infusion every 21 days for 3 cycles
Study NCT05024318 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Stereotactic Ablative Radiotherapy
Description: 42Gy delivered in 3 fractions
Study NCT06051942 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Robotic Waterjet Treatment
Description: The Aquablation therapy is a minimally invasive, image-guided, heat-free robotic therapy delivered by the AQUABEAM Robotic System. During Aquablation therapy, the AQUABEAM Handpiece is inserted transurethrally into the prostatic urethra. The operating physician then utilizes cystoscopy in conjunction with transrectal ultrasound (TRUS) imaging for real time visualization. The AQUABEAM Robotic System utilizes high-velocity sterile saline waterjet to resect and remove the prostate tissue according to the operating physician's treatment plan.
Study NCT05378789 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Nap
Description: ICU nurses can take a 20-mn nap between 2 and 5 am according to a rotation of personal.~Naps will be carried out with the help of a Nap and Up ® cocoon deckchair.
Study NCT06498102 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intermittent Fasting: Time Restricted Feeding During 6 Weeks
Description: Thirty-one healthy, young males (age: 27.5±6 years, body mass: 76.5±8.4 kg, and maximal oxygen uptake \[V̇O2max\]: 43.9±6.6 mL/kg/min) were randomly assigned to either TRF (n=14) or control group (n=17). TRF group followed an 16:8 intermittent fasting diet program for 6 weeks. Body composition, insulin sensitivity, resting substrate oxidation, and fat oxidation during cycling at 40% V̇O2max were assessed before and after the diet program.
Study NCT06497725 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Teleguidance-facilitated Airway Management
Description: tele-guidence will be provided by an experienced airway expert
Study NCT05024318 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Stereotactic Ablative Radiotherapy
Description: 42Gy delivered in 3 fractions
Study NCT05024318 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Nephrectomy
Description: Partial or total nephrectomy performed 9-12 weeks after first dose of Pembrolizumab
Study NCT05024318 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Nephrectomy
Description: Partial or total nephrectomy performed 9-12 weeks after first dose of Pembrolizumab
Study NCT05933291 — intervention group
Intervention type: DRUG
Intervention: steroid
Description: Moderate- or high-dose steroids
Study NCT05645666 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Well-being therapy
Description: Well-being therapy is a short-term, organized and problem-oriented treatment program that is based on Riff's psychological well-being model. Its purpose is to help patient in order to improve His/her functions in six dimensions; personal growth, environmental mastery, purposefulness of life, and autonomy, self-acceptance and positive relationships with others Therapists help patients find well-being experiences in their present and past lives and pay attention to these experiences, no matter how small or short they are.
Study NCT05793762 — intervention group
Intervention type: DEVICE
Intervention: Left virtual mirror therapy task
Description: the participant is seated on a chair facing the screen of the virtual mirror therapy device. both hands resting under the screen. The participant is asked, for each block of 20 seconds, to observe the visual feedback of the virtual left hand on the screen (flexion / extension movements of the fingers at 0.5 Hz).
Study NCT05793762 — intervention group
Intervention type: DEVICE
Intervention: Right virtual mirror therapy task
Description: the participant is seated on a chair facing the screen of the virtual mirror therapy device. both hands resting under the screen. The participant is asked, for each block of 20 seconds, to observe the visual feedback of the virtual right hand on the screen (flexion / extension movements of the fingers at 0.5 Hz).
Study NCT04714216 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: The Omnipod 5/Horizon HCL system
Description: The Omnipod 5/Horizon HCL system, consists of a disposable insulin infusion pump (or pod), a built-in model predictive control (MPC) insulin dosing algorithm, and a remote Personal Diabetes Manager (PDM) interface, that interact with a Dexcom G6 continuous glucose monitor (CGM) to automatically control insulin delivery based upon real-time glucose values. The PDM component also enables remote interaction with the system, including glucose monitoring as well as insulin dosing management and adjustments.
Study NCT05953961 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Therasphere 90Y
Description: Transarterial Radioembolization
Study NCT05953961 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Microwave Ablation
Description: Microwave Ablation
Study NCT06051539 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MR-001
Description: MR-001 is an autonomous neurorehabilitation system based on the principles of Rhythmic Auditory Stimulation intended to improve walking and ambulation in adult chronic stroke patients. MR-001 is intended to be a prescription use only device for use at home/community. The user operates the MR-001 System autonomously and the therapy progresses automatically once a user engages in a session. The MR-001 system consists of two foot sensors that measure walking, a touchscreen device preloaded solely with a proprietary software application, a headset, and charging equipment. The electronic components are powered by lithium-ion rechargeable batteries. Participants are asked to walk with the device for 3 times per week for 12 weeks. Each walking session is 30 minutes in length.
Study NCT05398354 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Active retirement
Description: During the intervention, the sensorimotor training program will have a progressive increase in load, the exercises will be divided into 3 levels of intensity: easy (without external load, during the first 8 weeks), intermediate (application of external load: elastic bands, shin guards and free weights, from the 9th to the 16th week) and advanced (increased external load compared to the previous level, from the 17th to the 24th week).~During the sessions we will still assess the intensity through the subjective perception of effort (RPE) scale. In addition, adherence and control of the level of control through the Physical Activity Enjoyment (PACES) survey applied to participants.
Study NCT05096390 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Axitinib Oral Tablet [Inlyta]
Description: Axitinib 5 up to 10mg twice a day
Study NCT05096390 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Axitinib Oral Tablet [Inlyta]
Description: Axitinib 5 up to 10mg twice a day
Study NCT05096390 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab Injection [Keytruda]
Description: Pembrolizumab intravenously over 30 min minutes at 200 mg every 3 weeks
Study NCT06094179 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Monoclonal antibody BAT6026
Description: 300mg Q4W group, 600mg Q4W group (at week 0,4,8,12) and 600mg Q2W group (at week 0,2,4,6,8,10,12,14)
Study NCT06094179 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: sodium chloride injection
Description: 300mg Q4W group, 600mg Q4W group (at week 0,4,8,12) and 600mg Q2W group (at week 0,2,4,6,8,10,12,14)
Study NCT05346757 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: miRFec test
Description: The miRFec test actually corresponds to the combination of fecal hemoglobin concentration (ie. FIT) and fecal miRNA expression
Study NCT01025661 — intervention group
Intervention type: OTHER
Group type: NO_INTERVENTION
Intervention: Chiropractic care
Description: Clinical examinations and treatments were performed at the outpatient clinic. The patients were assessed and treated by research assistants and the clinical care was supervised by state registered chiropractors. The choice of therapy and modality was pragmatic and based on the analysis of different functions such as mobility, tenderness, muscle tension and tone, and each patient's relative symptoms. Chiropractic care included high-velocity and low-amplitude techniques, soft-tissue or myofascial techniques, and arthrokinematic stabilizing exercises or a combination of these. Patients were treated in 1-2 sessions per week during the trial.
Study NCT05835492 — intervention group
Intervention type: DEVICE
Intervention: myCOPD
Description: myCOPD is a digital self-management application (app), that supports all elements of managing COPD by creating a supported self-help environment, and in turn reduce medical visits, and hospital admissions and re-admissions. myCOPD allows for key aspects of disease management, such as PR, to be provided remotely, based on a person's self-assessment. Furthermore, it can help people with COPD manage their condition at home, or anywhere away from a clinical setting. Successful implementation of myCOPD provides an opportunity to build capacity in primary and secondary care, and community teams where a blended approach with traditional PR and myCOPD is used. Studies have shown myCOPD is able to deliver similar improvements in symptoms and exercise tolerance compared to PR exercise-classes and helps patients admitted to hospital recover more quickly at home(5)(6). myCOPD is widely deployed across the NHS and is being used by patients in different areas of the UK.
Study NCT05435183 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Non-invasive high-frequency oscillatory ventilation
Description: Non-invasive high-frequency oscillatory ventilation generates high-frequency pressure fluctuations in the airway caused by the opening and closing of a solenoid valve.
Study NCT05435183 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Noninvasive Bilevel Positive Pressure Ventilation
Description: Noninvasive Bilevel Positive Pressure Ventilation
Study NCT06349785 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: rehabilitation of mechanically ventilated patients
Description: 1. mechanical ventilation~2. silicon resuscitation bag (500ml) connected to pressure manometer with an oxygen flow of 10 l.min-1~3. Endotracheal closed suction with pressure control ventilation (PCV)
Study NCT06349785 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: supportive care
Description: - Children in study group B will receive standard Physical therapy program including suction, percussion and vibration with total duration of session in group a will be 15 minutes, daily for successive two weeks
Study NCT06349785 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: supportive care
Description: - Children in study group B will receive standard Physical therapy program including suction, percussion and vibration with total duration of session in group a will be 15 minutes, daily for successive two weeks
Study NCT06780020 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Effects of different interventions using boxing
Description: The programs were designed to consist of 8 weeks (16 sessions) with a warm-up consisting of joint mobility and low-intensity aerobic activities, a 40-minute core component BOX and a 10-minute cool-down with static flexibility exercises.
Study NCT06780020 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Effects of different interventions using taekwondo
Description: The programs were designed to consist of 8 weeks (16 sessions) with a warm-up consisting of joint mobility and low-intensity aerobic activities, a 40-minute core component TKD and a 10-minute cool-down with static flexibility exercises.
Study NCT06780020 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Effects of different interventions using Elastic Band
Description: The programs were designed to consist of 8 weeks (16 sessions) with a warm-up consisting of joint mobility and low-intensity aerobic activities, a 40-minute core component Elastic Band and a 10-minute cool-down with static flexibility exercises.
Study NCT05925270 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: mhGAP-Remote
Description: One in-person session followed by standardized SMSs to reinforce the concepts learned in the first session. The intervention follows principles of the World Health Organization's Mental Health Gap Action Programme (mhGAP). Study interventionists can provide telephonic support to participants to implement the skills.